Surgery Partners, Inc. (SGRY)

Import this data to Google Sheets with:

=jivedata("SGRY","financials")

Full statements spill as a table. For one cell: =jivedata("SGRY","Revenue") or =jivedata("SGRY","Revenue","TTM"). Install the Jive Data add-on, then paste into a cell.

Surgery Partners, Inc.

SGRY • CIK 0001638833

(in thousands, except per share data)	FY 2023	FY 2024	FY 2025	TTM
Revenue from Contract with Customer, Including Assessed Tax	$2,743,300	$3,114,300	$3,308,700	$3,366,300
Operating Income (Loss)	$328,000	$348,800	$389,500	$383,800
Interest Income (Expense), Nonoperating, Net	$-193,000	$-201,700	$-272,600	$-281,400
Income (Loss) from Continuing Operations before Income Taxes, Domestic	$135,000	$147,100	$116,900	$102,400
Income Tax Expense (Benefit)	$-300	$134,600	$18,000	$20,500
Net Income (Loss), Including Portion Attributable to Noncontrolling Interest	$135,300	$12,500	$98,900	$81,900
Net Income (Loss) Attributable to Noncontrolling Interest	$147,200	$180,600	$176,800	$170,500
Net Income (Loss) Attributable to Parent	$-11,900	$-168,100	$-77,900	$-88,600
Labor and Related Expense	$793,800	$907,500	$971,000	$997,700
Supplies Expense	$745,000	$812,900	$878,900	$895,100
Professional Fees	$296,800	$357,100	$404,500	$411,200
Other Cost and Expense, Operating	$175,300	$201,700	$201,400	$213,000
Operating Costs and Expenses	$2,095,800	$2,368,700	$2,543,700	$2,608,400
General and Administrative Expense	$120,900	$138,700	$118,200	$121,700
Depreciation, Depletion and Amortization	$118,100	$152,600	$176,000	$177,200
Business Combination, Integration Related Costs	$61,700	$100,100	$73,900	$65,100
Income (Loss) from Equity Method Investments	$14,200	$19,500	$22,900	$22,300
Gain (Loss) Related to Litigation Settlement	$-10,600	$800	$-7,300	$-7,600
Gain (Loss) on Extinguishment of Debt	$-15,500	$-5,100	$-1,300	$-1,300
Other Nonrecurring (Income) Expense	$-6,400	$-20,000	$-8,700	$-10,200
Operating Expenses	$2,415,300	$2,765,500	$2,919,200	$2,982,500
Weighted Average Number of Shares Outstanding, Basic	125,613,000	126,122,000	127,209,000	129,014,000
Other Comprehensive Income (Loss), Cash Flow Hedge, Reclassification for Discontinuance, before Tax	$19,600	$19,600	$0	$0
StockRepurchaseProgramAuthorizedAmount1	—	$50,000	$50,000	$50,000
Stock Repurchase Program, Remaining Authorized Repurchase Amount	$46,000	$46,000	$46,000	$46,000

(in thousands, except per share data)	FY 2023	FY 2024	FY 2025	TTM
Cash and Cash Equivalents, at Carrying Value	$195,900	$269,500	$239,900	$216,700
Accounts Receivable, after Allowance for Credit Loss, Current	$496,400	$579,100	$602,200	$616,600
Property, Plant, and Equipment and Finance Lease Right-of-Use Asset, after Accumulated Depreciation and Amortization	$968,700	$1,088,300	$1,153,400	$1,122,700
Inventory, Net	$75,200	$88,400	$96,600	$98,800
Intangible Assets, Net (Excluding Goodwill)	$54,800	$45,700	$41,000	$41,000
Prepaid Expense, Current	$31,000	$36,400	$41,100	$48,300
Goodwill	$4,326,000	$5,068,000	$5,194,600	$5,203,500
Other Assets, Current	$96,500	$146,000	$170,900	$145,600
Investments in and Advance to Affiliates, Subsidiaries, Associates, and Joint Ventures	$184,100	$215,400	$234,000	$226,900
Assets, Current	$895,000	$1,119,400	$1,150,700	$1,126,000
Operating Lease, Right-of-Use Asset	$255,300	$295,700	$289,200	$278,500
Other Assets, Noncurrent	$103,300	$57,500	$56,800	$53,500
Assets	$6,876,700	$7,890,000	$8,119,700	$8,049,700
Long-term Debt and Lease Obligation	$2,701,800	$3,268,900	$3,602,900	$3,648,300
Operating Lease, Liability, Noncurrent	$248,900	$292,100	$279,900	$266,300
Deferred Income Tax Liabilities, Net	—	$39,200	$53,400	$54,400
Other Liabilities, Noncurrent	$41,100	$30,200	$41,200	$33,800
Redeemable Noncontrolling Interest, Equity, Carrying Amount	$327,400	$438,800	$395,500	$366,700
Accounts Payable, Current	$171,800	$208,700	$208,700	$175,200
Employee-related Liabilities, Current	$73,800	$60,400	$64,900	$73,100
Other Liabilities, Current	$204,100	$253,900	$242,600	$227,300
Long-term Debt and Lease Obligation, Current	$73,300	$101,400	$99,300	$102,900
Liabilities, Current	$523,000	$624,400	$615,500	$578,500
Preferred Stock, Value, Issued	$0	$0	$0	$0
Common Stock, Value, Outstanding	$1,300	$1,300	$1,300	$1,300
Additional Paid in Capital	$2,497,600	$2,520,900	$2,540,600	$2,544,400
Accumulated Other Comprehensive Income (Loss), Net of Tax	$57,500	$4,800	$-13,800	$-8,900
Retained Earnings (Accumulated Deficit)	$-569,200	$-737,300	$-815,200	$-866,100
Stockholders' Equity Attributable to Parent	$1,987,200	$1,789,700	$1,712,900	$1,670,700
Stockholders' Equity Attributable to Noncontrolling Interest	$1,047,300	$1,406,700	$1,418,400	$1,431,000
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest	$3,034,500	$3,196,400	$3,131,300	$3,101,700
Preferred Stock, Shares Authorized	20,310,000	20,310,000	20,310,000	20,310,000
Preferred Stock, Shares Issued	0	0	0	0
Common Stock, Shares Authorized	300,000,000	300,000,000	300,000,000	300,000,000
Common Stock, Shares, Issued	126,593,727	127,109,383	129,321,144	130,886,397
Derivative Asset, Notional Amount	$57,400	$10,800	$0	$0
Derivative Liability, Notional Amount	$17,800	$9,600	$13,800	$8,900

(in thousands, except per share data)	FY 2023	FY 2024	FY 2025	TTM
Net Income (Loss), Including Portion Attributable to Noncontrolling Interest	$135,300	$12,500	$98,900	$81,900
Net Cash Provided by (Used in) Operating Activities	$293,800	$300,100	$274,300	$258,000
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect	$-87,000	$73,600	$-29,600	$-33,400
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents	$195,900	$269,500	$239,900	$192,900
Depreciation, Depletion and Amortization	$118,100	$152,600	$176,000	$177,200
Payments to Acquire Property, Plant, and Equipment	$88,800	$90,400	$78,700	$70,400
Operating Lease, Expense	$35,200	$38,900	$37,800	$38,600
Payments to Acquire Businesses, Net of Cash Acquired	$80,000	$378,800	$162,100	$118,200
Proceeds from Sale of Productive Assets	$25,800	$2,600	$46,500	$3,900
Share-based Payment Arrangement, Noncash Expense	$17,700	$33,300	$14,800	$10,000
Payments to Acquire Equity Method Investments	$50,300	$1,700	$13,300	$9,500
Proceeds from Sale of Equity Method Investments	$1,400	$4,600	$1,500	$2,400
Gain (Loss) on Extinguishment of Debt	$-15,500	$-5,100	$-1,300	$-1,300
Payments for (Proceeds from) Other Investing Activities	$33,700	$24,800	$40,500	$13,700
Deferred Income Tax Expense (Benefit)	$-1,700	$131,500	$16,700	$19,400
Net Cash Provided by (Used in) Investing Activities	$-225,600	$-488,500	$-246,600	$-205,500
Income (Loss) from Equity Method Investments, Net of Dividends or Distributions	$2,200	$2,000	$800	$-400
Repayments of Long-term Debt	$807,100	$1,279,300	$1,039,800	$1,050,600
Proceeds from Issuance of Long-term Debt	$826,600	$1,729,700	$1,202,600	$1,170,400
Payments of Debt Issuance Costs	$24,300	$14,900	$4,100	$4,500
Payments of Ordinary Dividends, Noncontrolling Interest	$146,100	$170,500	$226,000	$213,200
Proceeds from (Payments to) Noncontrolling Interests	$8,200	$9,600	$600	$500
Proceeds from (Payments for) Other Financing Activities	$-12,500	$-12,600	$9,400	$11,500
Net Cash Provided by (Used in) Financing Activities	$-155,200	$262,000	$-57,300	$-85,900
Interest Paid, Excluding Capitalized Interest, Operating Activities	$169,600	$199,700	$256,800	$256,800
Income Taxes Paid, Net	$1,400	$1,600	$1,200	$1,200
Noncash or Part Noncash Acquisition, Fixed Assets Acquired	$18,000	$12,900	$14,200	$14,200
Increase (Decrease) in Accounts Receivable	$47,200	$72,100	$53,800	$73,700
Increase (Decrease) in Other Operating Assets and Liabilities, Net	$15,100	$46,800	$56,600	$40,900

Loading financial statements…

Import this data to Google Sheets with:

=jivedata("SGRY","financials")

Full statements spill as a table. For one cell: =jivedata("SGRY","Revenue") or =jivedata("SGRY","Revenue","TTM"). Install the Jive Data add-on, then paste into a cell.